The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

BACKGROUND: The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated. We here present a case of thrombotic microangiopathy triggered by Capnocytophaga canimorsus, illustrating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjørkto, Magnus Holter, Barratt-Due, Andreas, Nordøy, Ingvild, Dörje, Christina, Galteland, Eivind, Lind, Andreas, Hilli, Abdulkarim, Aukrust, Pål, Mjøen, Geir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852365/
https://www.ncbi.nlm.nih.gov/pubmed/33526010
http://dx.doi.org/10.1186/s12879-021-05789-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852365/
https://www.ncbi.nlm.nih.gov/pubmed/33526010
http://dx.doi.org/10.1186/s12879-021-05789-2

Ejemplares similares